Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-01-23 @ 8:38 AM
Study NCT ID:
NCT01652560
Status:
UNKNOWN
Last Update Posted:
2012-07-30
First Post:
2012-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Sponsor:
LiNanlin,Ph.D, Chief Physician,Clinical Professor
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
QTDS-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |